134 related articles for article (PubMed ID: 542586)
1. Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol.
Jeffcoate WJ; Silverstone JT; Edwards CR; Besser GM
Q J Med; 1979 Jul; 48(191):465-72. PubMed ID: 542586
[TBL] [Abstract][Full Text] [Related]
2. Personality characteristics and quality of life in patients treated for Cushing's syndrome.
Sonino N; Bonnini S; Fallo F; Boscaro M; Fava GA
Clin Endocrinol (Oxf); 2006 Mar; 64(3):314-8. PubMed ID: 16487442
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.
Starkman MN; Schteingart DE
Arch Intern Med; 1981 Feb; 141(2):215-9. PubMed ID: 6257194
[TBL] [Abstract][Full Text] [Related]
4. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
5. Cushing's syndrome: a psychiatric study of 29 patients.
Cohen SI
Br J Psychiatry; 1980 Feb; 136():120-4. PubMed ID: 7370477
[TBL] [Abstract][Full Text] [Related]
6. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric phenomenology in Cushing's disease.
Loosen PT; Chambliss B; DeBold CR; Shelton R; Orth DN
Pharmacopsychiatry; 1992 Jul; 25(4):192-8. PubMed ID: 1528959
[TBL] [Abstract][Full Text] [Related]
8. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
9. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
Friedman TC
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of psychiatric and psychological aspects of Cushing's syndrome.
Kelly WF; Kelly MJ; Faragher B
Clin Endocrinol (Oxf); 1996 Dec; 45(6):715-20. PubMed ID: 9039337
[TBL] [Abstract][Full Text] [Related]
11. Clotting changes in Cushing's syndrome: elevated factor VIII activity.
Dal Bo Zanon R; Fornasiero L; Boscaro M; Ruffato G; Luzzato G; Fabris F; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):268-77. PubMed ID: 6194060
[TBL] [Abstract][Full Text] [Related]
12. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
[TBL] [Abstract][Full Text] [Related]
13. Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease.
Sonino N; Fava GA; Belluardo P; Girelli ME; Boscaro M
Horm Res; 1993; 39(5-6):202-6. PubMed ID: 8314204
[TBL] [Abstract][Full Text] [Related]
14. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels.
Starkman MN; Schteingart DE; Schork MA
Psychosom Med; 1981 Feb; 43(1):3-18. PubMed ID: 6259680
[TBL] [Abstract][Full Text] [Related]
15. Alteration of plasma glucagon response to arginine after treatment in patients with diabetes mellitus, cushing's syndrome and hypothyroidism.
Seino Y; Goto Y; Kurahachi H; Sakurai H; Ikeda M
Horm Metab Res; 1977 Jan; 9(1):28-32. PubMed ID: 844789
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric disorders in Cushing's syndrome.
Pereira AM; Tiemensma J; Romijn JA
Neuroendocrinology; 2010; 92 Suppl 1():65-70. PubMed ID: 20829621
[TBL] [Abstract][Full Text] [Related]
17. Cushing's syndrome, tryptophan and depression.
Kelly WF; Checkley SA; Bender DA
Br J Psychiatry; 1980 Feb; 136():125-32. PubMed ID: 7370478
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome.
Haskett RF
Am J Psychiatry; 1985 Aug; 142(8):911-6. PubMed ID: 2992298
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric disorders associated with Cushing's syndrome.
Bratek A; Koźmin-Burzyńska A; Górniak E; Krysta K
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S339-43. PubMed ID: 26417792
[TBL] [Abstract][Full Text] [Related]
20. Psychiatric aspects of Cushing's syndrome.
Kelly WF
QJM; 1996 Jul; 89(7):543-51. PubMed ID: 8759496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
